SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Dr Reddys Labs
Dr Reddys Labs
BSE: 500124NSE: DRREDDYISIN: INE089A01023

25th-Jan-2013 11:50Source: BSE

Dr Reddys Labs - Dr. Reddy's announces the Launch of Desloratadine ODT (Orally Disintegrating Tablets)

Dr Reddys Laboratories has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex Reditabs in the US markets on January 24, 2013.

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(September 30, 2014)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo
3150

Powerful mix of both trader and investor packs with timely expert advice.

Technical
1890

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental
1890

For all investors looking to unearth stocks that are poised to move.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.